Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat for rectal sensory threshold in older adults with chronic constipation
jRCTs061200030Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of elobixibat in chronic constipation (3 arms), sponsored by EA Pharma Co., Ltd. Primary endpoint: Change in rectal defecatory urge sensory threshold. Started Feb 2021; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCTs061200030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061200030.